About Contact Us Careers

Neoplasm Treatment Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3898
Published Date: Jul 26, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Neoplasm Treatment Landscape

Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Bayer AG
Merck & Co., Inc.
Novartis AG
Abbott Laboratories
Exelixis, Inc.
Boehringer Ingelheim GmbH
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche
Amgen Inc.

Browse Key Market Insights with Data Illustration:

Neoplasm Treatment Market Size, Growth Forecasts 2024-2036

In the News

Exelixis Inc. announced the successful results for Cabozantinib in combination with immunotherapies in patients with advanced colorectal cancer.
Merck & Co announced the complete acquisition of Acceleron Pharma Inc., to explore the opportunities in medical research.

Author Credits: Radhika Pawar

Report ID: 3898
Published Date: Jul 26, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of neoplasm treatment is evaluated at USD 204.89 Billion.

The neoplasm treatment market size was valued at USD 187.51 Billion in 2023 and is likely to exceed USD 670.67 Billion by the end of 2036, expanding at over 10.3% CAGR during the forecast period i.e., between 2024-2036. Surging change in genetic mutations, increasing geriatric population are the major factors driving the market growth.

North America is expected to dominate majority industry share by 2036, attributed to rising cases of cancer in the region.

Thermo Fisher Scientific Inc., Bayer AG, Merck & Co., Inc., Novartis AG, Abbott Laboratories, Exelixis, Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Amgen Inc.

Inquiry Before Buying Request Free Sample